Clinical trial
Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity
NCT00460564 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00460564 |
|---|---|
| Title | Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity |
| Official title | A Multicenter Study to Evaluate the Efficacy and Safety in Patients With Post-Stroke Upper Limb Spasticity Receiving a Double-Blind, Placebo-Controlled GSK1358820 Treatment Followed by an Open-Label GSK1358820 Treatment |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post-Stroke Spasticity, Cerebrovascular Accident |
| Intervention type | Drug |
| Interventions | GSK1358820, Placebo |
| Enrollment | 109 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 16, 2007 |
| Last update posted | May 30, 2017 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: